EMPOWERED
By Pioneering
AUTOMATION

procedures can be made more efficient as well as being objective. Therefore, the results are qualitatively and quantitatively always the same and can consequently be assessed more easily in terms of quality management.

Wide Variety Of
INNOVATIVE
IVD Products And
SOLUTIONS

makes Monocent Inc, the core provider of all laboratory needs globally. Envisioning a monocentric model for the industry, we strive to be the one and only center to offer a comprehensive array of superior test systems and compatible instruments.

EVOLVING
Research
And
DEVELOPMENT

is one area that Monocent doesn’t hesitate to invest its resources. Creating and enhancing IVD products is a passion that drives our company.

EXTENSIVE
And Growing
Distribution
NETWORK

has been overwhelming, but we continue to provide our innovative products, customer service and technical support in over 50 countries to private institutions, academic/research sectors, laboratories and worldwide distributors.

A Culture of
EXCELLENCE
In Teamwork

produces extraordinary results. Operated by a dynamic group of highly skilled individuals each expert in their fields, Monocent Inc thrives on collaboration and communication.

IMMERSED
in Highest
Uncompromising
QUALITY

Monocent surpasses above and beyond regulatory QMS requirements and provides unforeseen superiority in IVD products.

MANUFACTURING
With
INTELLIGENCE
And Efficiency

increases performance and creates quality products with competitive pricing. Focused on lean production, using state of the art technology, Monocent inc. aims to deliver quality and excellence in research and diagnostics.

Covering
BROAD SCOPE
Of Infectious Diseases

caused by bacteria, viruses, fungi, or parasites. Tests are available across a variety of platforms such as, but not limited to, ELISA, RAPID and IFA.

previous arrow
next arrow
PlayPause
Slider

Monocent is a U.S-based IVD company and this is

What We Do

Development

Constant thirst for innovating new products and solutions in the field of diagnostics is embedded within our company’s DNA.

Manufacturing

Based on a strategic calculation of availability, performance and quality we ensure operational excellence and on-time delivery

Distribution

Having local familiarity with governments and regulations, contact networks and field experience, our international sales team is valuable resource for any distributor.

OUR NEXT

Event

We use every opportunity to reconnect with our distributors and help them grow their market. New ideas arises from the collaboration to renovate and provide solutions to the unmet market.

Monocent is committed to exhibit their products and services at all the medical trade shows around the world such as AACC, FIME, ANALITICA, MEDICA, MEDLAB.

Come and meet us at MEDICA, the world forum for medicine and learn more about our operations and how we can exceed your expectations. Click on the button below to schedule a meeting with our experts or just stop by our booth:

US Pavilion
Hall 3 / C30-3

ELISA

Enzyme-Linked Immunosorbent Assay

 

RAPID

Immunochromatog- raphy

 

CLIA

Chemiluminescence Immunoassay

 

IFA

Indirect Immunofluorescence Assay

 

IHC

Immunohistochemistry

 

PCR

Polymerase Chain Reaction

 

SEROLOGY

Test Kits

 

VET

Veterinary Test Kits

 

WIDE VARIETY OF

Test Systems

Our extensive Test System portfolio includes ELISA assays, Rapid tests, chemiluminescence assays, Serology tests, IFA test systems, Veterinary tests and instrumentation available to laboratories, Hospitals, Research Institutes and distributors worldwide.

  • ALLERGY
  • ANEMIA
  • AUTOIMMUNE DISEASE
  • BONE METABOLISM
  • CARDIAC MARKERS
  • DIABETES
  • DRUG OF ABUSE
  • FERTILITY
  • FOOD
  • HEPATITIS TESTS
  • INFECTIOUS DISEASE
  • NEONATAL
  • PARASITOLOGY
  • STEROIDS
  • THYROID
  • TUMOR MARKERS

LATEST GROUNDBREAKING PROJECT

HPV+STI Detection Through NGS

Monocent tireless innovation and collaborative work with talented developers and research companies, brings novel solutions to the IVD industry.

One of the most recent projects that Monocent has had the honor of being part of and be instrumental in its validation has to do with revolutionizing HPV and STI detection through Next-Generation Sequencing (NGS) Technology.

Through this method you have the ability to detect 27 HPVs and 13 STIs in one single reaction with a simple workflow. The accuracy and volume of information that this technology can provide, puts it ahead of all its competition. And given its low cost to setup and operate, this technology is the obvious choice for any medium to large size lab.

If you’re interested and like to be involved click below.

9
Subsidiaries
600
Test Kits
30
Countries
80
Distributors